In our earlier article, Pharmaceutical and Laboratory Facility Compliance, we mapped out the core compliance pillars regulators expect facilities to address, from cleanroom classification to documentation control. Of those pillars, cold chain integrity is often the least forgiving. A single temperature excursion can compromise a vaccine batch, invalidate a laboratory reference standard, or trigger a regulatory finding.
For Australian pharmaceutical manufacturers, distributors, and laboratories, cold chain compliance sits at the intersection of two frameworks: Therapeutic Goods Order (TGO) 100 – Standard for Storage and Transport, and Australia’s adoption of the PIC/S Guide to Good Manufacturing Practice.
Why Cold Chain Failures Are a Growing TGA Concern
As biologics, vaccines, and cell and gene therapies make up a larger share of the Australian pharmaceutical pipeline, TGA inspections are placing more weight on how facilities validate and monitor temperature-controlled storage.
Auditors are no longer satisfied with a working fridge and a logbook; they expect documented evidence that a facility’s cold storage was designed, built, and maintained to hold specified conditions under real operating stress, not just in ideal conditions.
What TGA and PIC/S Expect From Temperature-Controlled Storage
Under the PIC/S GMP Guide, facilities need qualification and validation (IQ/OQ/PQ) of cold rooms and freezers before they go into service, mapping studies that capture worst-case conditions such as full load, minimum load, and door-opening events, continuous monitoring with independent alarm systems, documented deviation and corrective-action processes for any excursion, and clear segregation of quarantined or rejected stock from released product.
Engineering the Facility: Where Most Compliance Gaps Start
In practice, many excursions trace back to the physical build rather than the monitoring software layered on top of it. Thermal bridging in wall panels, poor door seals, uneven airflow, and surfaces that aren’t rated for washdown or HACCP conditions all undermine a facility’s ability to hold validated conditions consistently.
Mapping and monitoring can only confirm what the structure is capable of; they can’t compensate for a poorly insulated build.
How CPL Group Supports Cold Chain Compliance in Australia
CPL Group has supplied thermal and containment solutions across Australasia for decades, and our Freezer Panels are engineered specifically for the ultra-low temperatures required by frozen pharmaceuticals and precision-controlled environments.
Their smooth, durable, moisture- and bacteria-resistant surfaces are built for HACCP-compliant facilities, and the modular panel system allows new sites to go live faster or existing sites to be upgraded with minimal disruption.
For facilities needing a full turn-key build, our Cold Storage Rooms combine advanced temperature control, state-of-the-art monitoring and alarming, and energy-efficient construction, with compliance and material documentation available on request, giving TGA auditors the paper trail they expect alongside the physical build.
Frequently Asked Questions
Does the TGA require validated temperature mapping for pharmaceutical cold storage?
Yes. Under TGO 100 and the PIC/S GMP Guide, storage areas holding temperature-sensitive medicines must undergo mapping studies confirming uniform conditions, including worst-case load and door-opening scenarios, before they can be used for validated storage.
What temperature range applies to standard pharmaceutical cold storage in Australia?
Most refrigerated pharmaceutical products are stored at 2–8°C, while frozen biologics and vaccines may require -15°C to -25°C or lower. The exact range is set by the product’s approved storage conditions, and the facility must be validated to hold that range under normal and worst-case operation.
How often should cold storage monitoring systems be calibrated?
PIC/S guidance expects calibration of monitoring probes and alarm systems on a defined schedule, typically annually, with more frequent verification checks in between. Records must be retained and available for TGA inspection.
What happens if a temperature excursion is detected?
Facilities need a documented deviation process that assesses product impact, quarantines affected stock, and records corrective and preventive actions. Unmanaged excursions are among the most common findings in TGA GMP inspections.
Preparing for Your Next TGA Inspection
If your site is preparing for a TGA inspection or a PIC/S readiness review, use the AU checklist below to identify physical and documentation gaps before an auditor does. Contact CPL Group for a facility assessment tailored to your pharmaceutical or laboratory operation.
Download our Australian pharmaceutical cold storage compliance checklist to identify potential engineering and documentation gaps before your next inspection. If you’re planning a new project or preparing for a TGA or PIC/S audit, contact CPL Group to discuss tailored cold storage solutions designed for pharmaceutical and laboratory environments.
